Brief: Celldex Reports Fourth Quarter And Year End 2022 Financial Results And Provides Corporate Update
28/02/2023 22:11
Feb 28 (Reuters) - Celldex Therapeutics Inc CLDX.O :
* CELLDEX REPORTS FOURTH QUARTER AND YEAR END 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CELLDEX THERAPEUTICS INC Q4 REVENUE $1.6 MILLION
* CELLDEX THERAPEUTICS INC Q4 LOSS PER SHARE $0.56
Source text for Eikon: ID:nGNX7kDD9k
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials